Display options
Cite
Alcorta-García MR, López-Villaseñor CN, Sánchez-Ferrer G, et al. Modulation of CYP2E1 metabolic activity in a cohort of confirmed caffeine ingesting pregnant women with preterm offspring. Mol Cell Pediatr. 2020;7(1):4doi: 10.1186/s40348-020-00096-3.
Alcorta-García, M. R., López-Villaseñor, C. N., Sánchez-Ferrer, G., Flores-Mendoza, H., Castorena-Torres, F., Aguilar-Torres, M. A., Sepúlveda-Treviño, C. M., Hernández-Hernández, J. A., López-Sánchez, R. C., & Lara-Díaz, V. J. (2020). Modulation of CYP2E1 metabolic activity in a cohort of confirmed caffeine ingesting pregnant women with preterm offspring. Molecular and cellular pediatrics, 7(1), 4. https://doi.org/10.1186/s40348-020-00096-3
Alcorta-García, M R, et al. "Modulation of CYP2E1 metabolic activity in a cohort of confirmed caffeine ingesting pregnant women with preterm offspring." Molecular and cellular pediatrics vol. 7,1 (2020): 4. doi: https://doi.org/10.1186/s40348-020-00096-3
Alcorta-García MR, López-Villaseñor CN, Sánchez-Ferrer G, Flores-Mendoza H, Castorena-Torres F, Aguilar-Torres MA, Sepúlveda-Treviño CM, Hernández-Hernández JA, López-Sánchez RC, Lara-Díaz VJ. Modulation of CYP2E1 metabolic activity in a cohort of confirmed caffeine ingesting pregnant women with preterm offspring. Mol Cell Pediatr. 2020 Jun 01;7(1):4. doi: 10.1186/s40348-020-00096-3. PMID: 32476096; PMCID: PMC7261717.
Copy Download .nbib Format: NLM
Share it on

Mol Cell Pediatr. 2020 Jun 01;7(1):4. doi: 10.1186/s40348-020-00096-3.

Modulation of CYP2E1 metabolic activity in a cohort of confirmed caffeine ingesting pregnant women with preterm offspring.

Molecular and cellular pediatrics

M R Alcorta-García, C N López-Villaseñor, G Sánchez-Ferrer, H Flores-Mendoza, F Castorena-Torres, M A Aguilar-Torres, C M Sepúlveda-Treviño, J A Hernández-Hernández, R C López-Sánchez, V J Lara-Díaz

Affiliations

  1. Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Avenida Ignacio Morones Prieto 3000 poniente, Colonia Doctores, CP 64710, Monterrey, Nuevo León, México.
  2. Hospital Regional Materno Infantil, Secretaria de Salud, Gobierno del Estado de Nuevo León, Avenida San Rafael 450, Colonia San Rafael, CP 67140, Ciudad Guadalupe, Nuevo León, México.
  3. Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Avenida Ignacio Morones Prieto 3000 poniente, Colonia Doctores, CP 64710, Monterrey, Nuevo León, México. [email protected].

PMID: 32476096 PMCID: PMC7261717 DOI: 10.1186/s40348-020-00096-3

Abstract

BACKGROUND: To ascertain interactions of caffeine ingestion, food, medications, and environmental exposures during preterm human gestation, under informed consent, we studied a cohort of Mexican women with further preterm offspring born at ≤ 34 completed weeks. At birth, blood samples were taken from mothers and umbilical cords to determine caffeine and metabolites concentrations and CYP1A2 (rs762551) and CYP2E1 (rs2031920, rs3813867) polymorphisms involved in caffeine metabolism.

RESULTS: In 90 pregnant women who gave birth to 98 preterm neonates, self-informed caffeine ingestion rate was 97%, laboratory confirmed rate was 93 %. Theobromine was the predominant metabolite found. Consumption of acetaminophen correlated significantly with changes in caffeine metabolism (acetaminophen R

CONCLUSION: Environmental exposures, especially acetaminophen ingestion during human preterm pregnancy, can modulate CYP2E1 metabolic activity.

Keywords: Caffeine; Cytochrome P-450 CYP1A2 inducers; Cytochrome P-450 CYP1A2 inhibitors; Cytochrome P-450 CYP2E1 inducers; Cytochrome P-450 CYP2E1 inhibitors; Cytochrome P-450 Enzyme System; Infant, Premature; Premature birth

References

  1. Int J Epidemiol. 2017 Oct 1;46(5):1389-1390k - PubMed
  2. BMC Pediatr. 2013 Jun 11;13:92 - PubMed
  3. Pharmacol Rev. 1999 Mar;51(1):83-133 - PubMed
  4. Am Fam Physician. 2014 Oct 15;90(8):548-55 - PubMed
  5. Am J Clin Nutr. 2018 Dec 1;108(6):1301-1308 - PubMed
  6. J Toxicol Environ Health A. 2008;71(15):984-91 - PubMed
  7. Environ Health Perspect. 1986 Dec;70:113-29 - PubMed
  8. J Am Diet Assoc. 2005 Jan;105(1):110-3 - PubMed
  9. J Clin Pharmacol. 2016 May;56(5):590-6 - PubMed
  10. Biochem Pharmacol. 1996 Feb 23;51(4):403-11 - PubMed
  11. Clin Pharmacol Ther. 2016 Jul;100(1):53-62 - PubMed
  12. Nature. 2015 Oct 1;526(7571):68-74 - PubMed
  13. Ginekol Pol. 2014 Jul;85(7):500-3 - PubMed
  14. Reprod Health. 2013 Jan 29;10:4 - PubMed
  15. Ann Epidemiol. 2008 Mar;18(3):172-8 - PubMed
  16. PLoS One. 2011;6(11):e27626 - PubMed
  17. J Pediatr. 2018 Jul;198:10-11 - PubMed
  18. N Engl J Med. 2006 May 18;354(20):2112-21 - PubMed
  19. J Anal Methods Chem. 2018 Aug 12;2018:2085059 - PubMed
  20. Rev Bras Ginecol Obstet. 2018 Dec;40(12):749-756 - PubMed
  21. J Clin Transl Res. 2017 Feb;3(Suppl 1):157-169 - PubMed
  22. Ann Epidemiol. 2005 Jul;15(6):460-6 - PubMed
  23. J Pediatr (Rio J). 2010 Mar-Apr;86(2):137-42 - PubMed
  24. Nutr J. 2013 Jul 01;12:91 - PubMed
  25. Biochem Pharmacol. 1994 May 18;47(10):1767-76 - PubMed
  26. Am J Obstet Gynecol. 2005 Feb;192(2):633-9 - PubMed
  27. Matern Child Health J. 2010 May;14(3):373-81 - PubMed
  28. Front Genet. 2012 Nov 02;3:229 - PubMed
  29. Clin Pharmacokinet. 1995 Feb;28(2):161-80 - PubMed
  30. Am J Clin Nutr. 2007 Jul;86(1):240-4 - PubMed
  31. BMC Med. 2013 Feb 19;11:42 - PubMed
  32. Toxicol Lett. 2013 Jun 7;219(3):269-78 - PubMed
  33. Epidemiology. 2002 Mar;13(2):165-71 - PubMed
  34. Clin Pharmacol Ther. 2001 Aug;70(2):121-5 - PubMed
  35. Handb Exp Pharmacol. 2011;(200):373-89 - PubMed
  36. Rev Med Chil. 2006 Apr;134(4):499-515 - PubMed
  37. Int J Environ Res Public Health. 2018 Oct 26;15(11): - PubMed

Publication Types

Grant support